secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sight Sciences, Inc. (SGHT)
CIK:        0001531177
Form:       8-K
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0001193125-23-264196
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 7.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Sight Sciences faces Medicare coverage threat for OMNI system; 63% of Surgical Glaucoma revenue at risk
--------------------------------------------------------------------------------

- WPS LCD classifies OMNI procedure as investigational, effective Dec 24, 2023; WPS states ~8% of 2022 Surgical Glaucoma revenue.
- Four other MACs proposed similar LCDs; combined five MACs ~63% of 2022 Surgical Glaucoma revenue.
- Company evaluating FY 2023 guidance due to uncertain coverage; update on Nov 7 earnings call.
- Company disputes LCD, submitted 36-month GEMINI study for publication; will pursue all remediation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1531177/000119312523264196/0001193125-23-264196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1531177/000119312523264196/d545751d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-264196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer